We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+10.56%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$120B
AUM Growth
+$5B
(+4.4%)
Cap. Flow
-$4.23B
Cap. Flow
% of AUM
-3.53%
Top 10 Holdings %
Top 10 Hldgs %
33.52%
Holding
335
New
4
Increased
58
Reduced
216
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$227M |
| 2 |
GSK
GSK
|
+$68.2M |
| 3 |
Elanco Animal Health
ELAN
|
+$48.2M |
| 4 |
Intel
INTC
|
+$45M |
| 5 |
Capri Holdings
CPRI
|
+$44.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$764M |
| 2 |
Microsoft
MSFT
|
+$272M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$262M |
| 4 |
Caterpillar
CAT
|
+$148M |
| 5 |
Novartis
NVS
|
+$142M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.41% |
| 2 | Technology | 30.05% |
| 3 | Industrials | 12.22% |
| 4 | Consumer Discretionary | 9.43% |
| 5 | Financials | 7.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Evercore
EVR
$11.8B
| $81.7M | 0.07% |
660,880
+39,600
| +6% | +$4.56M |
|
|
SWAV
152
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $81.4M | 0.07% |
285,100
-8,150
| -3% | -$2.26M |
|
153
Ametek
AME
$58.2B
| $80.7M | 0.07% |
498,400
-12,000
| -2% | -$1.75M |
|
154
Medtronic
MDT
$112B
| $78M | 0.07% |
884,800
-55,630
| -6% | -$4.79M |
|
155
Mobileye
MBLY
$2.2B
| $77.6M | 0.06% |
2,018,770
-2,300
| -0.1% | -$93.3K |
|
156
Live Nation Entertainment
LYV
$42.1B
| $75.4M | 0.06% |
827,740
-19,380
| -2% | -$1.51M |
|
157
Netflix
NFLX
$309B
| $74.3M | 0.06% |
1,686,100
-53,000
| -3% | -$1.95M |
|
158
IDEX
IEX
$17.3B
| $72.5M | 0.06% |
336,825
-12,670
| -4% | -$2.66M |
|
|
SCHW
159
Charles Schwab
SCHW
$187B
| $72.4M | 0.06% |
1,276,808
-29,100
| -2% | -$1.52M |
|
160
Pulmonx
LUNG
$87.6M
| $72.4M | 0.06% |
5,519,721
+17,000
| +0.3% | +$208K |
|
161
IQVIA
IQV
$39.3B
| $70.2M | 0.06% |
312,281
-1,500
| -0.5% | -$301K |
|
|
VMW
162
DELISTED
VMware, Inc
VMW
| $68.1M | 0.06% |
474,065
-2,930
| -0.6% | -$380K |
|
163
Salesforce
CRM
$158B
| $66.6M | 0.06% |
315,400
-63,000
| -17% | -$12.9M |
|
164
Alcon
ALC
$35B
| $65.3M | 0.05% |
794,865
| – | – |
|
165
Sanofi
SNY
$104B
| $61M | 0.05% |
1,132,090
-56,960
| -5% | -$3.06M |
|
166
Danaher
DHR
$144B
| $60.5M | 0.05% |
284,411
+3,836
| +1% | +$812K |
|
167
Lyft
LYFT
$6.63B
| $60.2M | 0.05% |
6,274,155
+2,013,844
| +47% | +$19.4M |
|
168
Uber
UBER
$153B
| $59.9M | 0.05% |
1,387,050
-5,800
| -0.4% | -$216K |
|
169
Charles River Laboratories
CRL
$12.8B
| $57.6M | 0.05% |
273,980
| – | – |
|
170
Ryanair
RYAAY
$31.3B
| $57M | 0.05% |
1,288,250
| – | – |
|
|
SWN
171
DELISTED
Southwestern Energy Company
SWN
| $55.2M | 0.05% |
9,181,700
-665,150
| -7% | -$3.43M |
|
172
Stratasys
SSYS
$774M
| $54.5M | 0.05% |
3,067,399
-108,350
| -3% | -$1.7M |
|
173
Norfolk Southern
NSC
$75.1B
| $52.4M | 0.04% |
231,100
+104,800
| +83% | +$22.3M |
|
174
HubSpot
HUBS
$10.5B
| $51.9M | 0.04% |
97,450
-6,900
| -7% | -$3.23M |
|
175
BJs Wholesale Club
BJ
$12.3B
| $51.4M | 0.04% |
816,000
+9,500
| +1% | +$657K |
|
Similar funds
VAM
Primecap Management's Q2 2023 Portfolio in Review
As of Q2 2023, Primecap Management held 335 positions worth $120B, up 4.4% from $115B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Primecap Management withdrew a net $4.23B in Q2 2023, closing 7 positions and reducing 216 holdings. Its most notable exit was Maxar Technologies Inc. Common Stock, an estimated $27M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Industrials.
Against the trend, Primecap Management opened a new position in Sphere Entertainment worth $17.1M.
- Primecap Management's largest Q2 2023 buy was Sphere Entertainment: 623,078 shares worth $17.1M.
- Primecap Management added most to Seagen Inc. Common Stock in Q2 2023, an estimated $227M increase.
- Primecap Management's biggest Q2 2023 reduction was Eli Lilly, cutting an estimated $764M.
- Primecap Management fully exited Maxar Technologies Inc. Common Stock in Q2 2023, selling an estimated $27M.
- Primecap Management's ten largest holdings make up 34% of its $120B portfolio in Q2 2023.
- Primecap Management opened 4 new positions and closed 7 in Q2 2023.
- Primecap Management's portfolio value rose 4.4% quarter-over-quarter to $120B.
Based on Primecap Management's 13F filing for Q2 2023, filed 11 Aug 2023.